Biojam marks its 10th anniversary in 2025, consolidating itself as a healthcare reference in Portugal and expanding its international presence.
Founded in 2015, Biojam has built a path defined by innovation and close collaboration with healthcare professionals, standing out in critical areas such as organ preservation for transplantation, oncology, rare diseases, and differentiated hospital products. Today, the company is the Iberian market leader in the treatment of Acute Lymphoblastic Leukemia, a disease that primarily affects children and young people.
According to Carlos Monteiro, CEO of Biojam:
"Our journey began with a dream: to bring innovation to healthcare and make a real contribution to people’s well-being. Today, as we look back, we feel proud of the path we have taken and the impact we have been able to create. More than a company, we want to be an agent of change, with the courage to innovate and deliver solutions that transform lives."
Over the past decade, Biojam has expanded beyond Portugal, establishing a presence in the BENELUX countries, opening a subsidiary in Spain, and more recently taking its first steps towards implementation in Brazil. At the same time, it has been strengthening its presence in Portuguese-speaking African countries (PALOP), extending its contribution to healthcare in territories with strong historical and cultural ties.
Commitment to science and talent
Biojam’s investment in creating value for the healthcare ecosystem is reflected in initiatives such as the Biojam Inovar Awards, which recognize and support outstanding work in clinical and translational research, and the Biojam Scholarships, aimed at students and professionals (particularly pharmacists), encouraging advanced training and the development of skills in critical areas for the future of healthcare.
A company made of people
Also recognized for its organizational culture, Biojam has been distinguished as a Great Place to Work, underlining the company’s commitment to valuing its teams and creating a positive, collaborative, and inspiring work environment.
Innovative in the field of rehabilitation as well, Biojam represents in Portugal a differentiated technological solution that supports mobility recovery in patients with motor limitations. This project is yet another step in the company’s commitment to improving quality of life and promoting patient autonomy.
With 10 years of history and eyes set on the future, Biojam reaffirms its mission: “Innovating in healthcare to save lives”, strengthening its commitment to science, healthcare professionals, and, above all, to patients and their families.
